Marcy l’Etoile (France), April 15, 2014 - Alexandre Mérieux will take on the role of Chief Executive Officer of bioMérieux and head its Management Committee. To step up the rollout of its strategic plan, a new organization is being deployed.
The Management Committee, led by Alexandre Mérieux, is in charge of implementing the strategy decided by bioMérieux’s Board of Directors, which remains chaired by Jean-Luc Belingard. The Committee’s main missions are to define the priority action and development areas, oversee strategic projects and allocate the necessary resources to the different departments within the Group.
Evolution of the operational organization
To continue bioMérieux’s international development and always better serve customers, three regional organizations with expanded responsibilities have been created: a Europe-Middle East-Africa region, an Americas region and an Asia-Pacific region. In parallel, two business units for bioMérieux’s customer segments, a Clinical Unit and an Industry Unit, have been established.
The Business Development, Molecular Biology and Quality departments will report to Jean-Luc Belingard. All other departments, including Investor Relations, will report to Alexandre Mérieux.
Jean-Luc Belingard, Chairman, stated: “I am very pleased to see Alexandre Mérieux take on the role of CEO. In the past three years, we have made major acquisitions and business agreements that hold exciting prospects for our Company. We will work with Alexandre to bring them to fruition with a shared humanist and long-term vision”.
Alexandre Mérieux, Chief Executive Officer, adds: “My new role is an extension of our family’s commitment to bioMérieux’s development. I will be able to count on Jean-Luc Belingard’s support, an outstanding Board and teams I know well and who have, time and time again, demonstrated their dedication to serving biologists and patients”.
Download
- Filename
- pr_biomerieux_new_organization_en.pdf
- Size
- 19 KB
- Format
- application/pdf